Modern Dental Europe Ltd. has acquired Permadental Holding B.V. from Foreman Capital
November 2013 — Modern Dental Europe Ltd. (MDL) has acquired Permadental Holding B.V. (Permadental) from Foreman Capital.
MDL produces dental prosthesis for dentists and doctors around the world. The company is part of the Modern Dental Holding Ltd group, one of the largest dental laboratories in the world, with production facilities in Shenzhen, China.
Permadental is the importer and supplier of dental prosthesis in the German market. The company has a track record of serving dentists for over 25 years by supplying them with crowns, bridges, implants and telescopic crowns, all manufactured in China.
Founded by Arent Foch and Guido ter Kuile in 2005, Foreman Capital is an independent investment company focused on investments in European companies that are active in trade, manufacturing and service provision.
Our role in the transaction
Oaklins' team in the Netherlands advised the buyer in this transaction.
Talk to the deal team
Related deals
Life & Mobility has attracted investor Bolster Investment Partners
Life & Mobility, a leading developer and manufacturer of premium mobility and rehabilitation solutions, has welcomed Bolster Investment Partners as a new shareholder. The partnership provides Life & Mobility with a strong long-term partner to support the company’s next phase of growth, with a continued focus on product innovation, strengthening its leading market position and further international expansion. The company’s mission remains to enhance the mobility, independence and quality of life of end users through innovative, sustainable and circular mobility solutions designed for multiple life cycles.
Learn moreAsana Gruppe has sold selected outpatient service areas to Luzerner Kantonsspital
Luzerner Kantonsspital (LUKS) has acquired key parts of Asana Spital Menziken AG’s outpatient services from Asana Gruppe AG, including its ambulance service, primary care practice and ambulatory care center. The transaction supports the long-term continuity of local medical care in the Swiss Wynen and Seetal regions and ensures these services remain available close to patients’ homes.
Learn moreLaboratoires Herbolistique has received a majority investment from Yotta Capital Partners and co-investors
Laboratoires Herbolistique has received a majority investment from Yotta Capital Partners alongside co-investors Ouest Croissance, Sodero and CE IDF, with Bpifrance, Océans Participations and the management team reinvesting.
Learn more